{{ $ActivityName }}
Male Female
< 5 years
5-10 years
11-20 years
>20 years
Multi-specialty hospital
Clinic/ nursing home
Government hospital/ medical college
Mixed
Tier 1 city
Tier 2 city
Tier 3 city
Rural area
<10
11-20
21-30
31-40
If any other
Males
Females
< 15 years
15-30 years
30-50 years
50 years and above
Family history of depression
Conflict at home or a stressful environment
Bullying at school or online
History of anxiety or other mental health issues
Substance abuse, including alcohol
Montgomery-Åsberg Depression Rating Scale (MADRS)
Hamilton Rating Scale for Depression (HAM-D)
Beck Depression Inventory (BDI)
APA guidelines
NICE guidelines
IPS guidelines
CANMAT guidelines
SSRI
SNRI
TCA
RIMA
Atypical antidepressant
Escitalopram
Sertraline
Fluoxetine
Fluvoxamine
Paroxetine
Any other
Yes
No
<20%
21 – 40%
41 – 60%
61 – 80%
>80%
5 mg
10 mg
15 mg
20 mg
<2 weeks
2 - 4 weeks
1-3 months
3- 6 months
2-4 weeks
> 6 months
Efficacy in depression symptoms
Favorable safety profile
Once a day dosing
Patient acceptance
15 Days
1 month
2-3 months
6 months
1 year or more
Always
Often
Sometimes
Rarely
Never
Very effective
Moderately effective
Slightly effective
Not effective
0-25%
26-50%
51-75%
76-100%
Most tolerable and most effective antidepressant
Equally tolerable and effective antidepressant
Less tolerable but equally effective antidepressant
Less tolerable and less effective antidepressant